Gabelli Analysts Boost Earnings Estimates for Vitamin Shoppe Inc (VSI)

Vitamin Shoppe Inc (NYSE:VSI) – Stock analysts at Gabelli lifted their FY2020 earnings per share (EPS) estimates for shares of Vitamin Shoppe in a research note issued to investors on Thursday, November 8th. Gabelli analyst D. Witkowski now anticipates that the specialty retailer will earn $0.50 per share for the year, up from their prior estimate of $0.45. Gabelli also issued estimates for Vitamin Shoppe’s FY2021 earnings at $0.80 EPS and FY2022 earnings at $1.10 EPS.

Several other equities research analysts have also issued reports on the stock. Zacks Investment Research lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Wednesday, October 17th. Morgan Stanley assumed coverage on Vitamin Shoppe in a research report on Monday, September 17th. They set an “equal weight” rating and a $14.00 target price for the company. Barclays downgraded Vitamin Shoppe from an “equal weight” rating to an “underweight” rating in a research report on Friday, September 7th. Finally, ValuEngine upgraded Vitamin Shoppe from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 4th.

Shares of NYSE VSI traded down $0.39 during midday trading on Friday, hitting $6.57. 73,685 shares of the company’s stock traded hands, compared to its average volume of 544,690. Vitamin Shoppe has a 1 year low of $3.35 and a 1 year high of $13.95. The firm has a market capitalization of $188.57 million, a P/E ratio of 16.85 and a beta of 0.94. The company has a quick ratio of 0.32, a current ratio of 1.96 and a debt-to-equity ratio of 0.32.

Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, November 7th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.08. The company had revenue of $276.64 million for the quarter, compared to analysts’ expectations of $278.79 million. Vitamin Shoppe had a negative net margin of 8.76% and a positive return on equity of 2.42%.

In other Vitamin Shoppe news, CEO Sharon M. Leite purchased 5,500 shares of the stock in a transaction on Friday, August 31st. The stock was acquired at an average price of $12.64 per share, with a total value of $69,520.00. Following the completion of the acquisition, the chief executive officer now owns 5,500 shares in the company, valued at $69,520. The acquisition was disclosed in a filing with the SEC, which is available at this link. 18.50% of the stock is currently owned by company insiders.

A number of hedge funds have recently made changes to their positions in VSI. Trexquant Investment LP purchased a new stake in shares of Vitamin Shoppe during the second quarter worth approximately $105,000. Nisa Investment Advisors LLC acquired a new position in shares of Vitamin Shoppe in the 2nd quarter valued at $129,000. Spark Investment Management LLC acquired a new position in shares of Vitamin Shoppe in the 2nd quarter valued at $227,000. AJ Wealth Strategies LLC acquired a new position in shares of Vitamin Shoppe in the 2nd quarter valued at $266,000. Finally, Laurion Capital Management LP acquired a new position in Vitamin Shoppe during the 2nd quarter worth about $274,000. Institutional investors own 89.24% of the company’s stock.

About Vitamin Shoppe

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Read More: What is Cost of Debt?

Earnings History and Estimates for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply